News
iECURE receives FDA Fast Track designation for neonatal onset Ornithine Transcarbamylase (OTC) deficiency treatment
iECURE, a gene editing company focused on the development of mutation-agnostic in vivo gene insertion, or knock-in, editing therapies for the treatment of liver...
Flagship Pioneering and Metaphore Biotechnologies collaborate with Novo Nordisk to develop next-generation obesity management...
Metaphore Biotechnologies, a Flagship-founded biotechnology company designing novel therapeutics by combining machine learning and molecular mimicry, has joined Flagship Pioneering in a research collaboration...
Touchlight, Cell and Gene Therapy Catapult and Complement Therapeutics to develop innovative manufacturing process...
The Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specialising in the advancement of the cell and gene therapy...
